Amphastar Pharmaceuticals Inventory 2012-2024 | AMPH

Amphastar Pharmaceuticals inventory from 2012 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
Amphastar Pharmaceuticals Annual Inventory
(Millions of US $)
2023 $106
2022 $104
2021 $93
2020 $97
2019 $111
2018 $69
2017 $64
2016 $80
2015 $71
2014 $82
2013 $70
2012 $51
2011 $
2009 $
Amphastar Pharmaceuticals Quarterly Inventory
(Millions of US $)
2024-06-30 $122
2024-03-31 $115
2023-12-31 $106
2023-09-30 $110
2023-06-30 $105
2023-03-31 $104
2022-12-31 $104
2022-09-30 $103
2022-06-30 $99
2022-03-31 $95
2021-12-31 $93
2021-09-30 $100
2021-06-30 $98
2021-03-31 $97
2020-12-31 $97
2020-09-30 $109
2020-06-30 $105
2020-03-31 $108
2019-12-31 $111
2019-09-30 $110
2019-06-30 $99
2019-03-31 $79
2018-12-31 $69
2018-09-30 $65
2018-06-30 $62
2018-03-31 $63
2017-12-31 $64
2017-09-30 $70
2017-06-30 $74
2017-03-31 $78
2016-12-31 $80
2016-09-30 $91
2016-06-30 $88
2016-03-31 $82
2015-12-31 $71
2015-09-30 $72
2015-06-30 $80
2015-03-31 $85
2014-12-31 $82
2014-09-30 $88
2014-06-30 $106
2014-03-31 $79
2013-12-31 $70
2013-09-30
2013-06-30
2013-03-31
2012-12-31 $51
2012-09-30
2012-06-30
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.438B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Bausch Health Cos (BHC) Canada $2.956B 2.23
Supernus Pharmaceuticals (SUPN) United States $1.771B 357.00
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Assembly Biosciences (ASMB) United States $0.117B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00